Advertisement
Advertisement
October 28, 2013
Reverse Medical's Microcatheter Approved for Neurovascular Use
October 29, 2013—Reverse Medical Corporation (Irvine, CA) announced US Food and Drug Administration 510(k) clearance and European CE Mark approval of the company's Reverse microcatheter product line for intracranial neurovascular use.
According to the company, the device has FDA clearance and CE Mark approval for use in neuro, peripheral, and coronary vasculature for the infusion of diagnostic agents, such as contrast media, and therapeutic agents, such as occlusion coils.
The Reverse microcatheter is available in 0.021-inch and 0.027-inch inner-lumen diameters. This new microcatheter line also provides physicians with a steam-shapeable tip option.
Stanley L. Barnwell, MD, performed the initial clinical case with the Reverse 27 microcatheter. In the company announcement, he commented, “I was impressed with the performance of this microcatheter—it provided smooth and stable delivery of the flow diverter device in distal anatomy.” Dr. Barnwell is Medical Director, Interventional Neuroradiology, at Oregon Health and Sciences University in Portland, Oregon.
Advertisement
Advertisement
